Eric Dube, Ph.D., Interviewed on Global Genes’ Rarecast Podcast Episode #311 With a New Identity, Travere Therapeutics Seeks to Find Its True Path With Eric Dube, CEO of Travere Therapeutics Listen to the podcast > Travere Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis Travere Therapeutics Virtual R&D Day
